687 related articles for article (PubMed ID: 6102234)
21. Depo Provera: a profile of current users.
Jarman H; Kovacs GT; Westcott M
Aust N Z J Obstet Gynaecol; 1990 Feb; 30(1):74-6. PubMed ID: 2140675
[TBL] [Abstract][Full Text] [Related]
22. Effects of hormonal and nonhormonal contraceptives on lactation and incidence of pregnancy.
Zacharias S; Aguilera E; Assenzo JR; Zanartu J
Contraception; 1986 Mar; 33(3):203-13. PubMed ID: 2941236
[TBL] [Abstract][Full Text] [Related]
23. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
Fraser IS
Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
[TBL] [Abstract][Full Text] [Related]
24. The return of fertility following discontinuation of oral contraceptives in Thailand.
Pardthaisong T; Gray RH
Fertil Steril; 1981 May; 35(5):532-4. PubMed ID: 7227568
[TBL] [Abstract][Full Text] [Related]
25. In utero exposure to steroid contraceptives and survival during infancy.
Gray RH; Pardthaisong T
Am J Epidemiol; 1991 Oct; 134(8):804-11. PubMed ID: 1835283
[TBL] [Abstract][Full Text] [Related]
26. Depo Provera: still controversial.
Wren LM
Int Health News; 1988 Feb; 9(2):2-3, 8. PubMed ID: 12179873
[TBL] [Abstract][Full Text] [Related]
27. A field study of the choice and continuity of use of three contraceptive methods in a rural area of Thailand.
Somboonsuk A; Xuto N; Gray RH; Grossman RA
J Biosoc Sci; 1978 Apr; 10(2):209-16. PubMed ID: 641076
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic study of different doses of Depo Provera.
Fotherby K; Koetsawang S; Mathrubutham M
Contraception; 1980 Nov; 22(5):527-36. PubMed ID: 6451351
[TBL] [Abstract][Full Text] [Related]
29. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
[TBL] [Abstract][Full Text] [Related]
30. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
31. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
[TBL] [Abstract][Full Text] [Related]
32. Serum high density lipoprotein cholesterol levels in women using a contraceptive injection of depot-medroxyprogesterone acetate.
Kremer J; de Bruijn HW; Hindriks FR
Contraception; 1980 Oct; 22(4):359-67. PubMed ID: 7449384
[TBL] [Abstract][Full Text] [Related]
33. Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-acting Systemic Agents for the Regulation of Fertility.
Gray RH; Parker RA; Diethelm P
Br J Obstet Gynaecol; 1981 Mar; 88(3):317-21. PubMed ID: 7008825
[TBL] [Abstract][Full Text] [Related]
34. [Sterility and infertility: two concepts].
Rochon M
Cah Que Demogr; 1986 Apr; 15(1):27-56. PubMed ID: 12268268
[TBL] [Abstract][Full Text] [Related]
35. The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?
Rosenfield A; Maine D; Rochat R; Shelton J; Hatcher RA
JAMA; 1983 Jun; 249(21):2922-8. PubMed ID: 6221125
[TBL] [Abstract][Full Text] [Related]
36. DMPA use above the age of 35 in Thai women.
Taneepanichskul S; Reinprayoon D; Phaosavadi S
Contraception; 2000 Apr; 61(4):281-2. PubMed ID: 10899485
[TBL] [Abstract][Full Text] [Related]
37. A prospective New Zealand study of fertility after removal of copper intrauterine contraceptive devices for conception and because of complications: a four-year study.
Wilson JC
Am J Obstet Gynecol; 1989 Feb; 160(2):391-6. PubMed ID: 2916624
[TBL] [Abstract][Full Text] [Related]
38. Continuation of injectable contraceptives in Thailand.
Narkavonnakit T; Bennett T; Balakrishnan TR
Stud Fam Plann; 1982 Apr; 13(4):99-105. PubMed ID: 6216633
[TBL] [Abstract][Full Text] [Related]
39. Comparative assessment of the effects of subdermal levonorgestrel implant system and long acting progestogen injection method on lipid metabolism.
Anwar M; Soejono SK; Maruo T; Abdullah N
Asia Oceania J Obstet Gynaecol; 1994 Mar; 20(1):53-8. PubMed ID: 8172528
[TBL] [Abstract][Full Text] [Related]
40. Timing of onset of contraceptive effectiveness in Depo-Provera users: Part I. Changes in cervical mucus.
Petta CA; Faundes A; Dunson TR; Ramos M; DeLucio M; Faundes D; Bahamondes L
Fertil Steril; 1998 Feb; 69(2):252-7. PubMed ID: 9496338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
